ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway.

about

ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway.

Item

http://www.wikidata.org/entity/Q53224664

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

ATM may be a protective factor ...... with the progesterone pathway.

@en

ATM may be a protective factor ...... with the progesterone pathway.

@nl

type

Item

label

ATM may be a protective factor ...... with the progesterone pathway.

@en

ATM may be a protective factor ...... with the progesterone pathway.

@nl

prefLabel

ATM may be a protective factor ...... with the progesterone pathway.

@en

ATM may be a protective factor ...... with the progesterone pathway.

@nl

P1476

ATM may be a protective factor ...... with the progesterone pathway.

@en

P2093

Chao Gu

http://www.w3.org/2001/XMLSchema#string

Chao Wang

http://www.w3.org/2001/XMLSchema#string

Chengcheng Ning

http://www.w3.org/2001/XMLSchema#string

Weiwei Shan

http://www.w3.org/2001/XMLSchema#string

Xiaojun Chen

http://www.w3.org/2001/XMLSchema#string

Xuezhen Luo

http://www.w3.org/2001/XMLSchema#string

Yinhua Yu

http://www.w3.org/2001/XMLSchema#string

Youji Feng

http://www.w3.org/2001/XMLSchema#string

Zhenbo Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer

DNA damage response pathways in tumor suppression and cancer treatment

Malignant tumors of the female reproductive system

Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines

Serial dilution curve: a new method for analysis of reverse phase protein array data

Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.

Germline mutations and polymorphisms in the origins of cancers in women.

The emerging genomic landscape of endometrial cancer.

Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

P2888

s13277-014-2712-4

P304

1529-1537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-014-2712-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25608836

http://www.w3.org/2001/XMLSchema#string